Author

Jennifer E. Shook

Observed names: J E Shook, J Shook, J. E. Shook, J. Shook, J.E. Shook, JENNIFER E. SHOOK, Jennifer Shook

Observed institutions: National Institutes of Health, State University of New York, University of Arizona, Medical University of South Carolina, Virginia Commonwealth University, National Institute of Environmental Health Sciences, Duke Medical Center, Virginia Commonwealth University Medical Center

OpenAlex ID: A5034502773

Differential Roles of Opioid Receptors in Respiration, Respiratory Disease, and Opiate-induced Respiratory Depression

1990 · Jennifer E. Shook, W. David Watkins, et al. · American Review of Respiratory Disease · 280

Peptide opioid antagonist separates peripheral and central opioid antitransit effects.

1987 · J E Shook, J T Pelton, et al. · Journal of Pharmacology and Experimental Therapeutics · 146

Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.

1989 · T H Kramer, J E Shook, et al. · Journal of Pharmacology and Experimental Therapeutics · 134

Design and synthesis of somatostatin analogs with topographical properties that lead to highly potent and specific .mu. opioid receptor antagonists with greatly reduced binding at somatostatin receptors

1988 · Wieslaw Kazmierski, William S. Wire, et al. · Journal of Medicinal Chemistry · 128

Cerebral oxygen availability by NIR spectroscopy during transient hypoxia in humans

1990 · N. B. Hampson, E. M. Camporesi, et al. · Journal of Applied Physiology · 92

Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.

1989 · J E Shook, T F Burks · Journal of Pharmacology and Experimental Therapeutics · 88

Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.

1989 · J E Shook, P K Lemcke, et al. · Journal of Pharmacology and Experimental Therapeutics · 81

Systemic administration of kainic acid differentially regulates the levels of prodynorphin and proenkephalin mRNA and peptides in the rat hippocampus

1991 · James Douglass, Laura Grimes, et al. · Molecular Brain Research · 77

CSF beta-endorphin and dynorphin in bulimia nervosa

1992 · T D Brewerton, R B Lydiard, et al. · American Journal of Psychiatry · 65

II. Regulation of gastrointestinal function by multiple opioid receptors

1988 · Thomas F. Burks, Deborah A. Fox, et al. · Life Sciences · 58

Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.

1987 · J E Shook, J T Pelton, et al. · Journal of Pharmacology and Experimental Therapeutics · 46

Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.

1988 · J E Shook, W Kazmierski, et al. · Journal of Pharmacology and Experimental Therapeutics · 42

Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.

1987 · J E Shook, J T Pelton, et al. · Journal of Pharmacology and Experimental Therapeutics · 39

Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.

1986 · J E Shook, J F Kachur, et al. · Journal of Pharmacology and Experimental Therapeutics · 35

Morphine dependence and diabetes. I. The development of morphine dependence in streptozotocin-diabetic rats and spontaneously diabetic C57BL/KsJ mice.

1986 · J E Shook, W L Dewey · Journal of Pharmacology and Experimental Therapeutics · 29

Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.

1989 · J E Shook, T F Burks, et al. · Journal of Pharmacology and Experimental Therapeutics · 23

Synthesis of highly .mu. and .delta. opioid receptor-selective peptides containing a photoaffinity group

1989 · Geoffrey Landis, George Lui, et al. · Journal of Medicinal Chemistry · 17

Depression of Ventilatory Responses to Hypoxia and Hypercapnia After Pentamorphone

1990 · M. Sherif Afifi, Peter S. A. Glass, et al. · Anesthesia & Analgesia · 13

A novel bioassay for the NK-2 neurokinin receptor: The guinea pig gallbladder

1986 · Jennifer E. Shook, Thomas F. Burks · Life Sciences · 13

Spinally mediated opioid antidiarrheal effects

1991 · Paul K. Lemcke, Jennifer E. Shook, et al. · European Journal of Pharmacology · 12

CSF opioids in panic disorder

1991 · K.T. Brady, R.B. Lydiard, et al. · Biological Psychiatry · 11

Synthesis and biological evaluation of Nα-hydroxysulfonyl-[Nle28,31]-CCK26–33

1986 · Elizabeth E. Sugg, Jennifer E. Shook, et al. · Life Sciences · 8

Characterization of the interaction of pentazocine and tripelennamine: Drug discrimination and mu-receptor binding assay

1984 · J.E. Shook, M.J. Kallman, et al. · Pharmacology Biochemistry and Behavior · 8

Cholecystokinic activity of Nα‐hydroxysulfonyl‐[Nle28,31]CCK26‐33 analogues modified at the C‐terminal residue

1988 · ELIZABETH E. SUGG, MARIANGELA SERRA, et al. · International journal of peptide & protein research · 7

Changes in opioid receptor selectivity following processing of peptide E: Effect on gut motility

1991 · Thomas P. Davis, Terrence J. Gillespie, et al. · Gastroenterology · 6

Works count: 33

Citation count: 1,471

H-index: 17

I10-index: 21